Dr. Arthur was inducted as a Fellow of the American Academy of Optometry (FAAO) in 2019 – a prestigious accolade given by the AAO to individuals who have accredited themselves and Optometry by their contributions to Optometry or Vision Science. He holds active memberships with the American Academy of Optometry (AAO), Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART), and a member of The Eye as a Biomarker for Alzheimer’s Disease (AD) Professional Interest Area (PIA) of the Alzheimer’s Association.

How to turn Onbacklight strobing

Diabetes and dementia are two of the most important public health crises in the US with huge health-care related costs and societal burden. Early diagnosis, referral, and management of patients with these conditions is crucial to slowing down disease progression. I am interested in the early detection, referral, and management of diabetic retinopathy (DR), diabetic macular edema (DME), and Alzheimer’s Disease (AD) using advanced retinal imaging modalities such as Spectral Domain Optical Coherence Tomography (SD-OCT), OCT Angiography (OCTA), Blue Autofluorescence (BAF) imaging, and Dual Wavelength (Blue-Green) Autofluorescence imaging. In addition, I am interested in developing a biological variable model that includes ethnicity, HbA1c, age, and sex in screening for individuals at risk of worse diabetes associated retinal neurodegeneration in underserved populations. Finally, I am interested in developing a toolkit of retinal, ocular fluid, and plasma biomarkers that may aid in screening for older individuals at risk for AD.

Isbacklight strobingbad for your eyes

Dr. Arthur serves as a frequent peer-reviewer having done more than 35 reviews for 9 different well known scientific journals: Scientific Reports, Investigative Ophthalmology and Visual Science (received exceptional good review on two occasions), BMC Ophthalmology, Optometry and Vision Science, Alzheimer’s & Dementia: The Journal of the Alzheimer's Association, Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM), Journal of Alzheimer's Disease, Translational Vision Science & Technology, and Ophthalmology Science. He also served as an abstract review team member for the 2021 Alzheimer's Association International Conference (AAIC) reviewing 30 abstracts for the conference.

Dr. Arthur received his Doctor of Optometry (OD) degree from Kwame Nkrumah University of Science and Technology in Ghana in 2014 followed by a PhD in Vision Science with a Biostatistics minor from Indiana University Bloomington, US in 2018. His PhD dissertation focused on detecting preclinical retinal changes in diabetic patients using advanced retinal imaging. Following his PhD, Dr. Arthur did a one-year postdoctoral research at the Quantitative Imaging and Eye-Brain Research Lab at the world renowned Bascom Palmer Eye Institute, University of Miami, researching retinal biomarkers for early diagnosis of cognitive impairment from 2018 to 2019. He then joined the Snyder/Alber Lab and the Butler Hospital Memory and Aging Program of University of Rhode Island and Brown University under the supervision of Drs. Peter Snyder, Jessica Alber, and Stephen Salloway, as a postdoctoral research fellow to work on a 5-year longitudinal study termed the Atlas of Retinal Imaging in Alzheimer’s Study (ARIAS). ARIAS is a more comprehensive study; an extension of the work he did at Bascom Palmer which seeks to examine retinal structural, vascular, and proteinopathy changes as they relate to cognitive, functional, proteomic, and biomarker changes across the cognitive aging spectrum. He still collaborates on this project till date.

Teaching/research interests: Ocular Disease Detection and Diagnosis; Vision Science; Epidemiology and Biostatistics; Geometric and Visual Optics; Advanced Retinal Imaging; Retinal biomarkers for early detection of diabetic retinopathy and diabetic macular edema; Ocular biomarkers for early detection of Alzheimer’s disease (AD) and related dementias; Biological variable model for screening and early detection of diabetic retinopathy and diabetic macular edema in underserved populations.